BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Healthtrust
UBS
Daiichi Sankyo
Mallinckrodt
Dow
Accenture
Argus Health
Chinese Patent Office
Cerilliant

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205874

« Back to Dashboard

NDA 205874 describes AURYXIA, which is a drug marketed by Keryx Biopharms and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug. Additional details are available on the AURYXIA profile page.

The generic ingredient in AURYXIA is ferric citrate. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ferric citrate profile page.
Summary for 205874
Tradename:AURYXIA
Applicant:Keryx Biopharms
Ingredient:ferric citrate
Patents:14
Formulation / Manufacturing:see details
Pharmacology for NDA: 205874
Ingredient-typeIron
Mechanism of ActionPhosphate Chelating Activity
Suppliers and Packaging for NDA: 205874
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AURYXIA ferric citrate TABLET;ORAL 205874 NDA Keryx Biopharmaceuticals, Inc. 59922-631 59922-631-01 200 TABLET, COATED in 1 BOTTLE (59922-631-01)
AURYXIA ferric citrate TABLET;ORAL 205874 NDA Keryx Biopharmaceuticals, Inc. 59922-631 59922-631-92 50 TABLET, COATED in 1 BOTTLE (59922-631-92)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 210MG IRON
Approval Date:Sep 5, 2014TE:RLD:Yes
Patent:➤ SubscribePatent Expiration:Feb 3, 2017Product Flag?YSubstance Flag?Delist Request?
Patented Use:CONTROL OF SERUM PHOSPHOROUS LEVELS
Patent:➤ SubscribePatent Expiration:Feb 18, 2024Product Flag?YSubstance Flag?YDelist Request?
Patent:➤ SubscribePatent Expiration:Apr 21, 2026Product Flag?Substance Flag?Delist Request?
Patented Use:CONTROL OF SERUM PHOSPHOROUS LEVELS

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Colorcon
Cipla
Deloitte
Fuji
Healthtrust
Julphar
Express Scripts
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot